NRX Pharmaceuticals, Inc. (NRXP) Total liabilities 2023–2025
NRX Pharmaceuticals, Inc. (NRXP) total liabilities at each fiscal year-end, per SEC filings.
$28.9MFY2025 · since FY2023: $19.0M → $28.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $28.9M | +7.5% |
| FY2024 | $26.9M | +41.1% |
| FY2023 | $19.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More NRXP financial trends
NRXP RevenueNRXP Net incomeNRXP Net marginNRXP Gross profitNRXP Gross marginNRXP Operating incomeNRXP Operating marginNRXP Operating cash flowNRXP Free cash flowNRXP Capital expendituresNRXP Return on equityNRXP Stock buybacksNRXP Dividends paidNRXP Total assetsNRXP Shareholders’ equityNRXP overview →